Related Experiment Video
Updated: Feb 8, 2026
Monitoring Conformational Dynamics of Single Unmodified Proteins using Plasmonic Nanotweezers
Published on: March 21, 2025
Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a
Ravi Salgia1, Mohit Kumar Jolly2, Tanya Dorff3
1Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA. rsalgia@coh.org.
Abstract:
Prostate cancer (PCa) is a leading cause of mortality and morbidity globally. While genomic alterations have been identified in PCa, in contrast to some other cancers, use of such information to personalize treatment is still in its infancy. Here, we discuss how PAGE4, a protein which appears to act both as an oncogenic factor as well as a metastasis suppressor, is a novel therapeutic target for PCa. Inhibiting PAGE4 may be a viable strategy for low-risk PCa where it is highly upregulated. Conversely, PAGE4 expression is downregulated in metastatic PCa and, therefore, reinstituting its sustained expression may be a promising option to subvert or attenuate androgen-resistant PCa. Thus, fine-tuning the levels of PAGE4 may represent a novel approach for personalized medicine in PCa.
Insights
Fine-tuning PAGE4 protein levels offers a new strategy for prostate cancer (PCa) treatment. Targeting PAGE4 could personalize therapies for both low-risk and metastatic forms of PCa.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer (PCa) remains a significant global health concern.
- Genomic insights into PCa are emerging but not yet widely used for personalized treatment.
- The protein PAGE4 exhibits dual roles in PCa, acting as both an oncogene and a metastasis suppressor.
Purpose of the Study:
- To explore PAGE4 as a novel therapeutic target for personalized prostate cancer treatment.
- To investigate the differential roles of PAGE4 in various stages of prostate cancer.
- To propose strategies for modulating PAGE4 levels to improve PCa outcomes.
Main Methods:
- Analysis of PAGE4 expression patterns in different PCa subtypes.
- Review of existing literature on PAGE4's function in cancer.
- Conceptualization of therapeutic strategies based on PAGE4's dual role.
Main Results:
- PAGE4 is highly upregulated in low-risk PCa, suggesting inhibition as a potential therapy.
- PAGE4 is downregulated in metastatic PCa, indicating its potential as a tumor suppressor.
- Modulating PAGE4 levels presents a personalized medicine approach for PCa.
Conclusions:
- Fine-tuning PAGE4 levels represents a novel therapeutic avenue for prostate cancer.
- Targeting PAGE4 offers potential for personalized treatment strategies in both early-stage and advanced PCa.
- Further research into PAGE4 modulation could lead to improved PCa patient outcomes.
Related Concept Videos
01:20Conformity
02:11Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
02:11Proteins: From Genes to Degradation
02:20Conformations of Butane
01:19Protein Dynamics in Living Cells
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...
02:29Conformations of Cycloalkanes